Acute Kidney Injury Treatment Market, By Type (Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, and Postrenal Acute Kidney Injury), By Treatment (Therapy and Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and On
Acute Kidney Injury Treatment Market, By Type (Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, and Postrenal Acute Kidney Injury), By Treatment (Therapy and Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Acute kidney injury (AKI) refers to an abrupt loss of kidney function, resulting in the build-up of waste products in the blood that would normally be removed by the kidneys. It is a serious condition that requires prompt medical care to prevent further kidney damage and failure. Global acute kidney injury treatment market growth is driven by rising prevalence of comorbid conditions such as diabetes and hypertension that increases the risk of AKI. Furthermore, development of novel drugs and treatment approaches has expanded therapeutic options for patients. However, lack of awareness among people and healthcare providers about AKI can hamper the market growth.
Market Dynamics:
Global acute kidney injury treatment market growth is driven by rising geriatric population who are more susceptible to AKI due to age-related decline in kidney function. According to the United Nations, the number of people aged 65 years and above is projected to reach over 1.5 billion by 2050. Growing prevalence of chronic kidney diseases due to lifestyle changes can also drive the market growth. However, high costs associated with renal replacement therapies can limit widespread adoption. Lack of awareness about early diagnosis of AKI can hamper the market growth. Development of biomarkers for early detection of AKI presents lucrative opportunities for market players to expand their offerings in this area. Real-time monitoring of fluid status offers real-time customized care. Digital health solutions can also aid remote patient management.
Key features of the study:
This report provides in-depth analysis of the global acute kidney injury treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global acute kidney injury treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fresenius Medical Care AG & Co. KGaA, Baxter, Angion Biomedica Corp, AM-Pharma, and Quark Pharmaceuticals, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global acute kidney injury treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acute kidney injury treatment market
Detailed Segmentation-
Type Insights (Revenue, USD Bn, 2019 - 2031)
Prerenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury
Postrenal Acute Kidney Injury
Treatment Insights (Revenue, USD Bn, 2019 - 2031)
Therapy
Drugs
Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Angion Biomedica Corp.
AM-Pharma
Quark Pharmaceuticals, Inc.
Baxter International, Inc.
Fresenius Medical Care AG & Co. KGaA
Braun Melsungen AG
Asahi Kasei Medical Co., Ltd.
LG Chem
Kringle Pharma, Inc.
AstraZeneca
Amgen Inc.
Gilead Sciences
Roche
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Bristol-Myers Squibb
Eli Lilly and Company
Novartis AG
AbbVie Inc.
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Bovine Serum Albumin Market, By Form
Global Bovine Serum Albumin Market, By Grade
Global Bovine Serum Albumin Market, By Application
Global Bovine Serum Albumin Market, By End User
Global Bovine Serum Albumin Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Bovine Serum Albumin Market, By Form, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Dry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Liquid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Bovine Serum Albumin Market, By Grade, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Technical and Diagnostic Grade
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Research/Reagent Grade
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Food Grade
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Bovine Serum Albumin Market, By Application, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
In Vitro Diagnostics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Vaccine Production
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Biochemical Assay
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Bovine Serum Albumin Market, By End User, 20192031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Pharmaceutical and Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Contract Research Organizations (CROs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Bovine Serum Albumin Market, By Region, 2019 - 2031, (USD Mn)